Interesting Engineering on MSN4h
FDA approves first-ever rapid-acting insulin biosimilar for diabetes treatmentFirst-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...
Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...
News Medical on MSN1d
Diabetes drugs may boost brain health but experts warn of risksRAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent ...
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...
Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, ...
Groundbreaking research reveals how common diabetes medications might offer unprecedented protection against heart attacks ...
More than 7,500 students with Type 1 diabetes enter college every year, and the number is only growing. At the University of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback